Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplantation (Children's Hospital Los Angeles)
- Development stage
- Unknown
- Lead developer
- Children's Hospital Los Angeles
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Cell Therapies, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral, Rectal, Intranasal
01
Overview
Fecal microbiota transplantation (FMT) is an investigational biologic therapy being evaluated in a Phase 1 clinical trial at Children's Hospital Los Angeles for the treatment of autism spectrum disorder (ASD) with associated gastrointestinal (GI) symptoms. The therapy involves the administration of fecal matter from a healthy donor into the gastrointestinal tract of the recipient, with the goal of modifying the gut microbiome. This approach is based on the theory that dysbiosis, or an imbalance in gut bacteria, may contribute to both GI and behavioral symptoms in individuals with ASD through the gut-brain axis. The trial, led by Dr. Sonia Michail, specifically evaluates the safety and efficacy of a single dose of FMT delivered via upper endoscopy to the jejunum in children and young adults aged 5 to 17.
- Other names
- FMTfecal microbiota transplantstool transplantMicrobiota Transfer Therapyfecal microbiota transplantation-Children's Hospital Los Angeles-autism spectrum disorder
Beyond the preview
Go deeper on fecal microbiota transplantation (Children's Hospital Los Angeles).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplantation (Children's Hospital Los Angeles).